Aprea Therapeutics, Inc. (NASDAQ:APRE) Financings

Aprea Therapeutics, Inc.

Financings

RaiseDate
Private placement of shares of common stock (or pre-funded warrants) with warrants
Announced: about US$5.6M · US$0.89 a share · Warrants at US$0.765 · Maxim Group LLC
Dealers: Maxim Group LLC (lead)
Insiders: Certain insiders of the Company are among the purchasers
Use of proceeds: General corporate purposes and research and development expenses
Jan 29, 2026
Private placement of private placement financing
Closed: US$3.1M raised · US$1.165 a share · Warrants at US$1.04 for 60 months · Maxim Group LLC
Dealers: Maxim Group LLC (lead)
Insiders: The CEO, the CFO and a Board member participated alongside external investors
Use of proceeds: General corporate purposes and research and development expenses
Dec 18, 2025

Read by 6ix AI from the company's releases